Keyword: BeiGene


Amgen and China’s BeiGene in Oncology Partnership

04.11.2019 - US biotech Amgen has agreed to take a 20.5% stake in China’s BeiGene as the two companies enter into a strategic collaboration to develop cancer drugs. The move significantly...

Strategy & Management

Along the Acquisition Trail

17.04.2018 - For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...


Celgene to Buy into China’s BeiGene

13.07.2017 - US biopharmaceutical company Celgene has agreed to buy a stake in China’s BeiGene and help to develop and commercialize that company’s investigational treatment for tumor cancers...